BioSpace News Archive

The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association on the signing of a revised Canada-United States-Mexico Agreement by the three countries

Complications Often Go Undetected but Can Contribute to Misuse and Overdose, According to The Journal of the American Osteopathic Association

Bone Bank Allografts (BBA), a leading provider of regenerative medicine technologies to the surgical community, announced a multi-year partnership agreement with Yankee Alliance, a group purchasing organization (GPO) with more than 15,000 members across the United States.

OrthoPediatrics Corp. (“OrthoPediatrics”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that it is commencing an underwritten public offering of its common stock.

Admera Health, a molecular diagnostics company, welcomes Omar Karame as Chief Financial Officer to the company

A new report released by the independent, non-profit Alliance for Cell Therapy Now, highlights the need for a national effort to measure outcomes related to regenerative cell therapies, as well as increased federal funding for research at the National Institutes for Health (NIH) and expanded capacity at the Food and Drug Administration (FDA) to support this rapidly growing field

As a physician-owned, specialty hospital focused on orthopaedics, as well as plastic and reconstructive surgery, Crystal Clinic Orthopaedic Center is in a unique position to drive new breakthroughs and standards in care through physician-led innovations.

PharmaForce International’s recent syndicated report benchmarks leading Biosimilar sales and marketing organizations in the United States.

Spherix Incorporated (Nasdaq: SPEX) today announced that it has closed the CBM BioPharma, Inc. transaction and is working to develop these cancer drugs.

The CDMO receives the Corporate Health Award’s seal of excellence for the second time